Product: Glipizide 2.5 mg Extended-release tablets, 30-count bottle, Rx Only, Manufactured By: Patheon Pharmaceuticals Inc Cincinnati, OH  45237, NDC 00591-0900-30
Reason for recall: Failed Dissolution Specifications: Glipizide 2.5 mg ER  Tablets exceeded  dissolution specification rates for the 10 hour testing point.
Recall initiated: 20160630
Status: Terminated
Classification: Class II
Recall type: Voluntary: Firm initiated